[49] In a phase III double-blind, randomized, controlled trial supported by Eli Lilly, nondiabetic adults with a body mass index of 30 or more, or 27 or more and at least one weight-related complication, excluding diabetes, were randomized to receive once-weekly, subcutaneous tirzepatide (5, 10, or 15 mg) or placebo
However, there are individual studies for each medication showing their efficacy and researchers are closely examining their results in various settings
If you want 2.5mg from a 20mg/mL vial: (2.5 / 20) x 100 = 12.5 units
To put it into perspective, for someone weighing 240 lbs, this translates to an average loss of 33 lbs with Semaglutide, compared to 48 lbs with tirzepatide
You can start taking semaglutide 1 week after your last Mounjaro dose under the supervision of your healthcare provider
Understanding what is in your vial, and why, allows you to make informed decisions and to recognize if a formulation switch is warranted